✅ 9 criteria passed
❌ 2 criteria to solve
Use our free online form builder to create any type of form for tctmd.com.
Beauty and simplicity.
Use templates. No coding. Embed anywhere. Get emails. Collect data.
opens a new window
TCTMD - tctmd.com
https://tctmd.com
TCTMD: the most comprehensive online resource in interventional cardiology with coverage of treatment of cardiovascular disease.
https://tctmd.com
TCTMD - tctmd.com
TCTMD: the most comprehensive online resource in interventional cardiology with coverage of treatment of cardiovascular disease.
Alternate URL | Hreflang |
https://www.tctmd.com/topic/tctmd | en |
Great, a redirect is in place to redirect traffic from your non-preferred domain. All versions of your page point to the same URL.
Attribute | Value |
ⓘ abstract | TCTMD: the most comprehensive online resource in interventional cardiology with coverage of treatment of cardiovascular... |
ⓘ viewport | width=device-width, initial-scale=1.0 |
ⓘ viewport | width=device-width |
ⓘ The results of our semantic analysis are shown below using the website's language.
They are the main concepts covered by tctmd.com.
Each concept has a confidence score. The higher it is, the more important the topic is relative to the page.
Topics | |
Cardiovascular disease Confidence: 83%
|
|
Interventional cardiology Confidence: 75%
|
❌ tctmd.com website speed is slow. Page speed is important for visitors and search engines.
Get insights to improve your page loading time.
This domain loads at the median speed of 1.9 seconds.
tctmd.com is faster than approximately 46 percent of the web. Your website page speed needs to be as fast as you can make it, without compromising the customer experience.
A good goal to achieve is a loading time of 2 seconds on desktop and mobile devices.
ⓘ This website is ranked #473.434 by Alexa.
This rank is traffic based. The lower the rank is, the better the domain is ranked.
Country | Rank |
India | #134.124 |
Mobile Rendering
This website seems to be optimized for Mobile Visitors.
Phone
Tablet
A good text to HTML ratio is anywhere from 25 to 70%.
This percentage refers to the visible text ratio, as opposed to HTML elements, image tags and other non-visible information.
Great, we found headings on this page.
However, you have not defined a top level heading, or <H1>. It is used to define the most important heading.
We recommend using one top level heading to set up a semantic relationship between that heading and the remainder of the content on a page. It clearly describes to the readers and the search engines what it is about.
For a better readability, only the first 20 <H2> tags are shown below.
2nd level heading |
Top user menu |
Main navigation |
Signal of ımpaired sapien xt durability in midterm follow-up |
Some a-fib patients may need a bit more aspirin after pcı: augustus |
Solid 2-year outcomes for portico, with paravalvular leak rare |
Slides |
Pcı-stent deployment and dilation strategies, and how ı diagnosed and treated my patient |
Drug-coated balloons: state of the art in the face of controversy |
Therapy choice of tavr vs. savr |
News |
Vıctorıa trial of vericiguat for worsening hf meets primary endpoint |
Grief and cvd: simple regimen may lower risk |
ıschemıa-ckd: routine ınvasive approach no help in ckd patients with stable cad |
ıschemıa: ınvasive strategy no better than meds for cv events |
Early data favorable for new rnai therapies to reduce triglycerides |
ınclisiran in fh: safe, cuts ldl in this challenging group |
Two small series support role for cerebral protection in tavr |
Evaporate hints at slowed plaque progression with ıcosapent ethyl |
Lower cholesterol cuts cv events: treat stroke to target trial |
Videos |
3rd level heading |
ıschemıa: ınvasive strategy no better than meds for cv events |
ıschemıa-ckd: routine ınvasive approach no help in ckd patients with stable cad |
More adverse events, higher costs with ımpella: new observational studies |
Pcı-stent deployment and dilation strategies, and how ı diagnosed and treated my patient |
Synergy bp-des & optimizing antiplatelet therapy after pcı in high-bleeding risk patients |
Become a premıum member or log ın to view exclusive content |
Regıster for free or log ın to view this content |
5th level heading |
Become a member |
Sign up for our newsletter |
6th level heading |
Advertisement (5) |
Partner events |
Upcoming conferences |
Conference coverage |
Sign ın |
Forgot your password? |
Search tctmd |
Cme tıtle |
Submit an event |
We found 39 images on this website.
16
ALT attributes are missing on your image tags. The issue affects 10 actual different images that could be loaded more than once in your page.
Alternative text allows you to add a description to an image.
Google rely on alternative text attributes to determine relevance to a search query. Alternative text also makes an image more likely to appear in a Google image search.
It looks like you're missing alternative text for 16 images on tctmd.com. Check your website to make sure it's specified for each image on the page.
For a better readability, only the first 50 internal links are shown below.
Anchor | Type | URL |
Register | text | /register |
No anchor | empty | / |
News | text | /news |
Conferences | text | /conferences |
Slides & More | text | /slides |
Slides | text | /slides |
CME | text | /cme |
Live Cases | text | /see-all/video?subtype=live%20case |
Member Cases | text | /cases |
Podcasts | text | /see-all/audio |
Cath Lab Forum | text | /cathlab |
Manuscripts | text | /see-all/manuscript |
Topics | text | /topic/coronary |
Clinical Cardiology | text | /topic/clinical-cardiology |
Coronary | text | /topic/coronary |
Endovascular | text | /topic/endovascular |
Heart Failure | text | /topic/heart-failure |
Heart Rhythm | text | /topic/heart-rhythm |
Imaging & Physiology | text | /topic/imaging |
Policy & Practice | text | /topic/policy-practice |
Structural Heart | text | /topic/structural |
Videos | text | /videos |
Fellows Forum | text | /fellows-forum |
image | /news/signal-impaired-sapien-xt-durability-midterm-follow | |
News • Interventional | text | /news |
PCR London Valves 2019 | text | /conference/pcr-london-valves-2019 |
Signal of Impaired Sapien XT Durability in Midterm Follow-up | text | /news/signal-impaired-sapien-xt-durability-midterm-follow |
Michael O'Riordan | text | /staff/michael-oriordan |
AHA 2019 | text | /conference/aha-2019 |
Some A-fib Patients May Need a Bit More Aspirin After PCI: AUGUSTUS | text | /news/some-fib-patients-may-need-bit-more-aspirin-after-pci-augustus |
Todd Neale | text | /staff/todd-neale |
image | /news/some-fib-patients-may-need-bit-more-aspirin-after-pci-augustus | |
Solid 2-Year Outcomes for Portico, With Paravalvular Leak Rare | text | /news/solid-2-year-outcomes-portico-paravalvular-leak-rare |
image | /news/solid-2-year-outcomes-portico-paravalvular-leak-rare | |
image | https://www.tctmd.com/conference/aha-2019 | |
See all | text | /slides |
Presentation | text | /search?type=slide&subtype=presentation&searched=true |
TCT 2019 | text | /tct2019 |
PCI-Stent Deployment and Dilation Strategies, and How I Diagnosed and Treated My Patient | text | /slide/pci-stent-deployment-and-dilation-strategies-and-how-i-diagnosed-and-treated-my-patient |
Drug-Coated Balloons: State of the Art in the Face of Controversy | text | /slide/drug-coated-balloons-state-art-face-controversy |
Therapy Choice of TAVR vs. SAVR | text | /slide/therapy-choice-tavr-vs-savr |
See all | text | /news |
VICTORIA Trial of Vericiguat for Worsening HF Meets Primary Endpoint | text | /news/victoria-trial-vericiguat-worsening-hf-meets-primary-endpoint |
Grief and CVD: Simple Regimen May Lower Risk | text | /news/grief-and-cvd-simple-regimen-may-lower-risk |
L.A. McKeown | text | /staff/la-mckeown |
ISCHEMIA-CKD: Routine Invasive Approach No Help in CKD Patients With Stable CAD | text | /news/ischemia-ckd-routine-invasive-approach-no-help-ckd-patients-stable-cad |
Todd Neale | text | /staff/todd-neale |
ISCHEMIA: Invasive Strategy No Better Than Meds for CV Events | text | /news/ischemia-invasive-strategy-no-better-meds-cv-events |
Shelley Wood | text | /staff/shelley-wood |
Early Data Favorable for New RNAi Therapies to Reduce Triglycerides | text | /news/early-data-favorable-new-rnai-therapies-reduce-triglycerides |
Anchor | Type | URL |
image | https://www.veithsymposium.org | |
image | http://www.caci.org.ar/ | |
image | https://www.nytranscathetervalves.org/ | |
image | https://www.livevalves.com/ | |
No anchor | empty | http://www.crf.org/ |
No anchor | empty | https://twitter.com/tctmd |
No anchor | empty | https://www.facebook.com/tctmdnews/ |
No anchor | empty | http://www.linkedin.com/groupınvitation?gid=123406 |
No anchor | empty | https://www.instagram.com/tctmd/ |
image | https://www.healthonnet.org/honcode/conduct.html?honconduct749589 | |
Constructive | text | https://constructive.co |
ⓘ Domain Registrar | NETWORK SOLUTIONS, LLC |
ⓘ Registration Date | 02/06/2000 24 years, 2 months, 13 days ago |
ⓘ Last Modified | 09/12/2019 4 years, 7 months, 10 days ago |
ⓘ Expiration Date | 02/06/2020 Expired |
Domain |
publiclab.org |
samford.edu |
keyence.com |
bellamihair.com |
tctmd.com |
spbtv.com |
turfoo.fr |
imd.org |
arbeiterkammer.at |
SOCIAL MEDIA PRESENCE
You're doing quiet good on social media!
Social shares are a key signal, among many others, that search engines use to evaluate the rankings of a website. Asking people to share your pages, adding visible social share buttons and make great quality content are 3 of the most powerful ways to grow your social presence.